📖 Approx. 8 minutes ／ Updated 2026.05.08
The dispensing pharmacy industry has seen a proliferation in numbers alongside the advancement of the separation of dispensing and prescribing. However, in recent years, it has faced a multitude of challenges, including a shortage of pharmacists, changes in revenue structures due to dispensing fee revisions, and the promotion of regional healthcare visions. In this environment, M&A is garnering attention as a key management strategy for achieving sustainable growth and contributing to regional healthcare. In particular, the grouping of dispensing pharmacies by medical corporations holds the potential to enhance management efficiency and improve patient services through strengthened collaboration. This article details the current state of dispensing pharmacy M&A, the strategic value brought about by collaboration with medical corporations, and the specialized issues to consider when contemplating M&A.
Current State of the Dispensing Pharmacy M&A Market and Background of Realignment
In recent years, M&A activities in the dispensing pharmacy industry have become increasingly active. This is driven by the increase in the number of pharmacies, promoted by national policies for the separation of dispensing and prescribing, coupled with the current reality of management being strained by difficulties in hiring pharmacists and continuous reductions in dispensing fees. Notably, dispensing fee revisions since 2020 have aimed to differentiate between large chain pharmacies and community-based “caretaker pharmacies,” leading to the sophistication and diversification of functions required of pharmacies, such as certifications for regional support systems and specialized medical institution collaboration pharmacies.
Furthermore, with the advancement of regional healthcare visions, pharmacies are expected to go beyond mere dispensing services and strengthen their roles as members of the regional integrated care system, including responding to home-based medical care, participating in multi-professional collaboration, and introducing online dispensing guidance. To adapt to these changes, strengthening the management base and efficient personnel allocation are essential, and expanding business scale or acquiring specialized expertise through M&A can be effective means. Additionally, the growing need for business succession due to the aging society is also a factor invigorating the M&A market.
Strategic Benefits and Legal Considerations of Medical Corporation Grouping
The primary motivations for medical corporations to group dispensing pharmacies include stable prescription reception, improved management efficiency, and enhanced patient convenience. By collaborating with affiliated medical institutions, not only is prescription reception stabilized and the pharmacy’s management base strengthened, but medical institutions also benefit from establishing a consistent medical care provision system for patients. Moreover, cost reduction effects can be expected through joint drug procurement and streamlined administrative operations.
However, there are legal restrictions on medical corporations directly managing dispensing pharmacies. The Medical Care Act strictly limits medical corporations from entering profit-making businesses, and direct management of dispensing pharmacies is generally not permitted. Therefore, when medical corporations group dispensing pharmacies, it is common for individuals closely related to the medical corporation (such as the chairman of the board) to inherit the pharmacy business, or for a related company (such as a stock company) of the medical corporation to be established and operate the pharmacy business. In this context, depending on the type of medical corporation (e.g., with or without contribution-based equity, specific medical corporation, social medical corporation), funding methods, decision-making processes, and the potential for future changes in members or return of funds can influence M&A strategy. Understanding these legal and institutional frameworks and establishing appropriate schemes are key to success.
Business Valuation and Transfer Price Issues for Dispensing Pharmacies
The transfer price in M&A of dispensing pharmacies varies depending on various factors, but generally, it is estimated to be around 0.5 to 1.5 times the annual sales. For pharmacies with annual sales ranging from 200 million to 1 billion yen, the transfer price often falls between 50 million and 500 million yen. However, this is merely a guideline and can vary significantly based on the characteristics of individual pharmacies.
The main points for business valuation include the following:
- Location and Prescription Reception Source Concentration: Valuation differs depending on whether it is a “monzen” pharmacy (high concentration of prescriptions from a specific medical institution) or a general pharmacy (receives prescriptions from multiple medical institutions). Locations with good patient accessibility, such as near stations or within commercial facilities, tend to receive higher valuations.
- Pharmacist Staffing System: The stable availability of pharmacists, including the chief pharmacist, is a crucial evaluation item as it directly relates to the continuity of pharmacy operations. Amidst ongoing difficulties in hiring pharmacists, pharmacies with stable staffing tend to be highly valued.
- Revenue Structure of Dispensing Fees: The acquisition status of various dispensing fee add-ons, such as the generic drug dispensing system support add-on, regional support system add-on, caretaker pharmacy function, and home-based care response, and their contribution to revenue are evaluated. Future revenue projections, considering the impact of dispensing fee revisions, are also important.
- Inventory Valuation: The valuation of drug inventory directly impacts the transfer price. The presence of long-term aged inventory and the handling of drugs with disposal risk are also examined.
- Permit Status: The status of pharmacy establishment permits and quality management systems such as GVP (Good Vigilance Practice) and GPSP (Good Post-marketing Study Practice) are also subject to evaluation.
These elements are comprehensively evaluated, and the transfer price is determined with reference to methods such as DCF (Discounted Cash Flow), comparable company analysis, and asset-based valuation. In particular, the trend of dispensing fee revisions directly impacts revenue, making detailed analysis of their effects indispensable.
Legal and Institutional Considerations in the M&A Process
When proceeding with M&A of dispensing pharmacies, it is essential to fully understand the legal and institutional considerations unique to the healthcare industry.
- Succession of Permits: Pharmacy establishment permits cannot, in principle, be transferred or succeeded. In the case of a business transfer M&A, the acquiring party must obtain a new pharmacy establishment permit. Therefore, consideration must be given to the fact that a certain period will be required from the execution of the M&A to the commencement of operations. In the case of a stock transfer, since the corporate status continues, re-acquisition of the permit is not necessary, but a notification of director changes is required.
- Continued Employment of Pharmacists: Pharmacy operations require the securing of pharmacists who meet the staffing standards stipulated by the Pharmaceutical and Medical Device Act. The intention of the chief pharmacist to continue employment is particularly important and must be thoroughly confirmed during due diligence (DD) before the M&A agreement is concluded.
- Choice between Business Transfer and Stock Transfer: The main M&A methods are business transfer and stock transfer. Business transfer has the advantage of allowing selective inheritance of individual assets and liabilities, but it requires re-acquisition of permits and renegotiation of contractual relationships. Stock transfer is relatively simpler in terms of procedures because the corporate status continues, but it carries the risk of inheriting all rights and obligations, including off-balance sheet liabilities. From a tax perspective, the taxation of capital gains and tax rates, as well as the treatment of consumption tax, differ between the two, making it important to select the optimal scheme in consultation with experts.
- Treatment of Business Tax: In the case of a business transfer, consumption tax may be levied on the transferor. Furthermore, the possibility of real estate acquisition tax and other taxes being incurred for the transfer of specific assets such as real estate must also be considered.
These legal and tax-related issues are complex, and meticulous examination by experts is indispensable.
Future Prospects of Regional Healthcare Collaboration and Dispensing Pharmacy M&A
In Japan, which is facing a super-aged society, the establishment of a regional integrated care system is an urgent issue, and the role played by dispensing pharmacies within this system is becoming increasingly important. Pharmacies are being called upon to transform from mere drug supply points into “caretaker pharmacies” that support the health of local residents, serving as a core entity in multi-professional collaboration.
Strengthening the management base and expanding business scale through M&A can be effective means to enhance the ability to respond to such transformations. For example, a group operating multiple pharmacies can undertake initiatives that are difficult for individual pharmacies, such as wide-area deployment of pharmacists, training of specialized pharmacists, enhancement of advanced pharmaceutical management functions, and active participation in home-based medical care. Furthermore, by deepening collaboration with medical corporations, it is expected that a regional healthcare collaboration system integrated with clinics and hospitals can be established, contributing to the seamless provision of medical services to patients. From the perspective of promoting regional healthcare visions, the realignment and strengthening of pharmacy functions through M&A hold the potential to contribute to the improvement of regional healthcare quality in the future.
Points to Note Regarding Tax and Labor in M&A
In M&A of dispensing pharmacies, specialized consideration of tax and labor matters is indispensable. For both the transferor and the transferee, tax burdens corresponding to the M&A scheme and the continuity of employee employment conditions are important issues.
- Capital Gains Tax: When an individual business owner transfers a pharmacy or when corporate shares are transferred, capital gains are taxed. In the case of a business transfer, it is taxed as business income or real estate capital gains, and in the case of a stock transfer, it is taxed as capital gains on stocks, etc., with different tax rates and calculation methods for each. In particular, when an individual medical institution is incorporated (becomes a medical corporation) and established as a medical corporation with contribution-based equity, complex tax implications may arise from the transfer of that equity. While the return of funds in fund-contribution type medical corporations is generally not subject to capital gains tax, M&A involving a medical corporation owning a pharmacy as a related company may indirectly affect changes in the members of the medical corporation itself or the handling of funds.
- Consumption Tax Treatment: In the case of a business transfer, consumption tax is levied on certain assets subject to transfer (e.g., drug inventory, medical equipment, real estate). It is necessary to clearly distinguish between taxable and non-taxable assets and calculate the accurate tax amount.
- Labor Issues: To ensure that pharmacists and administrative staff can continue to work with peace of mind after M&A, clear agreements are necessary regarding the continuation of employment contracts, working conditions, retirement benefit regulations, and welfare programs. Particularly in the case of a business transfer, it is generally required to conclude new employment contracts with employees by the successor, and employee consent is essential. For a smooth succession, it is recommended to hold explanatory meetings for employees before closing to address their concerns.
These tax and labor-related matters are directly linked to the smooth operation of the business after M&A, making it important to thoroughly discuss them in advance with experts such as tax accountants and social insurance labor consultants.
M&A of dispensing pharmacies is not merely a transaction of business but a crucial management decision that shapes the future of regional healthcare. It requires an understanding of the legal and institutional constraints unique to the healthcare industry, complex business valuations, and specialized knowledge of tax and labor matters. Therefore, when considering M&A, we recommend consulting with specialists focused on healthcare M&A. At M&A Medical, based on our extensive experience and expertise in M&A and business succession for medical corporations and dispensing pharmacies, we provide optimal proposals tailored to your institution’s or company’s situation and comprehensive support through to closing. Please feel free to utilize our free consultation service.
Consult M&A Medical for Healthcare Succession
M&A Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support institution certified by the Small and Medium Enterprise Agency, we support the successful transfer of clinics and medical corporations facing succession issues, as well as strategic acquisitions, on a success fee basis.
- Initial consultation and preliminary assessment are free
- No retainer or monthly fees (success fee only)
- Strict confidentiality (proceeding under NDA)
- Services available nationwide across all 47 prefectures and all medical specialties
Please consult us early in the consideration phase, whether you want to know the market value, have no successor, or are considering joining a group.